ketanserin has been researched along with Burns in 5 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Burns: Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metabolites of arachidonic acid are possible mediators of local renal vasoconstriction in burn shock." | 7.68 | Renal vasoconstriction induced by arachidonic acid during burn shock in rats. ( Haugan, A; Kirkebø, A, 1990) |
| "Metabolites of arachidonic acid are possible mediators of local renal vasoconstriction in burn shock." | 3.68 | Renal vasoconstriction induced by arachidonic acid during burn shock in rats. ( Haugan, A; Kirkebø, A, 1990) |
| "Edema was assessed by FITC-albumin extravasation." | 1.42 | 5-HT2a receptor antagonism reduces burn-induced macromolecular efflux in rats. ( Hernekamp, JF; Klein, H; Kneser, U; Kremer, T; Schmidt, K, 2015) |
| "The ketanserin-treated groups demonstrated improved cardiac index, decreased pulmonary artery pressures, and smaller arteriovenous oxygen content differences compared to the control group in the early postburn period." | 1.27 | The effect of ketanserin, a specific serotonin antagonist, on burn shock hemodynamic parameters in a porcine burn model. ( Holliman, CJ; Larsen, KR; Meuleman, TR; Pace, NL; Port, JD; Stanley, TH; Warden, GD, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernekamp, JF | 1 |
| Klein, H | 1 |
| Schmidt, K | 1 |
| Kneser, U | 1 |
| Kremer, T | 1 |
| Holliman, CJ | 1 |
| Meuleman, TR | 1 |
| Larsen, KR | 1 |
| Port, JD | 1 |
| Stanley, TH | 1 |
| Pace, NL | 1 |
| Warden, GD | 1 |
| Haugan, A | 2 |
| Kirkebø, A | 2 |
| Dhennin, C | 1 |
| Vesin, L | 1 |
| Feauveaux, JF | 1 |
5 other studies available for ketanserin and Burns
| Article | Year |
|---|---|
5-HT2a receptor antagonism reduces burn-induced macromolecular efflux in rats.
Topics: Animals; Burns; Edema; Endothelium, Vascular; Hemodynamics; Ketanserin; Leukocytes; Mesentery; Rats, | 2015 |
The effect of ketanserin, a specific serotonin antagonist, on burn shock hemodynamic parameters in a porcine burn model.
Topics: Animals; Blood Pressure; Body Temperature; Burns; Disease Models, Animal; Heart Rate; Hemodynamics; | 1983 |
Renal vasoconstriction induced by arachidonic acid during burn shock in rats.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Biphenyl Compounds; Burns; Epoprostenol; Ketanserin; M | 1990 |
Local renal ischemia during burn shock in rat effected by thromboxane A2 and serotonin.
Topics: Animals; Blood Pressure; Burns; Indomethacin; Ischemia; Ketanserin; Kidney Cortex; Male; Phentolamin | 1986 |
Ketanserin as an adjunct to burn treatment.
Topics: Adult; Burns; Drug Evaluation; Humans; Ketanserin; Middle Aged; Pilot Projects; Wound Healing | 1988 |